Dilated cardiomyopathy: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• DMD 0
• SGLT2 0
• TP53 0
• IL-1 1
• IL-17 0
• NRF2 0
• PI3K 0
• PPAR 0
• CD40 0
• ERK 0
• GLP-1 0
• IL-6 0
• MAPK 0
• mTOR 0
• NLRP3 0
• PD-1 0
• PDE4 0
• PINK1 0
• RUNX1 0
• STAT3 0
• STING 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAMS · R21

  Failure to resolve an adaptive stress state contributes to Duchenne Muscular Dystrophy Severity

  University of Southern California· Los Angeles, Egyesült Államok· 211 650 USD awarded in fiscal year 2026· until 2028. aug.

• NIH NIA · R44

  IND-enabling program for novel stimulant FBD-400

  Firebird Pharmaceuticals, Inc.· Boston, Egyesült Államok· 1 654 275 USD awarded in fiscal year 2026· until 2028. máj.

• NIH NINDS · R56

  Treg-mediated tolerance of dystrophin immunity

  University of California-Irvine· Irvine, Egyesült Államok· 549 500 USD awarded in fiscal year 2026· until 2027. aug.

• NIH NIAMS · R01

  Targeting protein N-terminal methyltransferase in muscle diseases

  Purdue University· West Lafayette, Egyesült Államok· 587 757 USD awarded in fiscal year 2026· until 2031. jún.

• NIH NIAMS · R21

  Lipin1 and Micro-Dystrophin Gene Therapies for DMD: Independent and Combined Therapeutic Potential

  Wright State University· Dayton, Egyesült Államok· 377 077 USD awarded in fiscal year 2026· until 2028. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  From n=1 to many: Scaling-up gene editing for future heart therapies (ONE2MANY)

  Klinikum Der Technischen Universität München (Tum Klinikum)· Muenchen, Németország· EU contribution 1 499 468 EUR· until 2031. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Arrhythmogenesis in Dilated Cardiomyopathy: Role of Mechano-Electric Coupling (RhythMEC)

  Albert-Ludwigs-Universitaet Freiburg· Freiburg, Németország· EU contribution 265 648 EUR· until 2028. aug.· 2 countries

• European Commission (Horizon Europe) · HORIZON-EIC

  Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions (CARDIOREPAIR)

  European Molecular Biology Laboratory· Heidelberg, Németország· EU contribution 4 617 351 EUR· until 2028. szept.· 2 countries

• European Commission (Horizon Europe) · HORIZON-EIC

  Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families. (DCM-NEXT)

  Stichting Amsterdam Umc· Amsterdam, Hollandia· EU contribution 4 137 669 EUR· until 2027. szept.· 5 countries

• European Commission (Horizon Europe) · HORIZON-ERC

  Beyond the chromosome: unravelling the interplay between inter-chromosomal genome architecture and mRNA biogenesis (TRANS-3)

  Universita Degli Studi di Torino· Torino, Olaszország· EU contribution 1 769 998 EUR· until 2028. aug.

10 of 275 running projects, newest first. Listed amounts together: 147,8 M USD + 14,8 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 7
• Organoids 1
• Mendelian Randomization Analysis 8
• CRISPR-Cas Systems 2
• Gene Expression Profiling 23
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Exome Sequencing 11
• Proteomics 9
• Metabolomics 3
• Immunohistochemistry 3
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 20
• Machine Learning 8
• Deep Learning 2
• Cohort Studies 15
• Genome-Wide Association Study 11

• Shared Genetic Architecture Between Mental Disorders and Heart Failure Subtypes: A Comprehensive Multitrait Genome-Wide Analysis.

  J Am Heart Assoc, 2026. okt.

• Whole-genome sequencing identifies a c.1282C > T missense variant in Taurine Transporter (TauT) associated with taurine-mediated dilated cardiomyopathy in a family of domestic shorthair cats.

  J Mol Cell Cardiol, 2026. szept.

• The bidirectional genetic causality between immunocyte phenotypes and dilated cardiomyopathy: A bidirectional Mendelian randomization study.

  Medicine (Baltimore), 2026. júl.

• Integrative Observational and Genetic Evidence From the UK Biobank Supports Carotid Intima-Media Thickness as a Window Into Cardiac Remodeling.

  J Am Heart Assoc, 2026. júl.

• Engineered Heart Tissues Facilitate Noncoding Variant Studies in Cardiomyopathy.

  Circ Res, 2026. jún.

• Antibody-mediated immune responses and cardiovascular disease: a Mendelian randomization study.

  Exp Biol Med (Maywood), 2026. máj.

• Mendelian randomization and transcriptome analysis reveal depression-driven regulatory patterns of the immune microenvironment in myocardial infarction and heart failure.

  Front Immunol, 2026. jan.

• Potential Risk Factors and Therapeutic Targets for Dilated Cardiomyopathy Identified Through Mendelian Randomization Analysis.

  J Am Heart Assoc, 2025. dec.

• Systolic and diastolic blood pressure, abdominal obesity, and alcohol consumption contribute to the risk of hypertrophic and dilated cardiomyopathies in European and East Asian populations.

  BMC Med, 2025. dec.

• The Utility of Genome-Wide Association Studies in Inherited Arrhythmias and Cardiomyopathies.

  Genes (Basel), 2025. dec.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.